couldn't have said it better.
bump
loaded up guys.
will close green today.
see Bloomberg article.
bump
thaanks
makes thrx even more vaaluable
says like peanut butter and jelly : )
thank you
Bloomberg
Glaxo May Buy Theravance to Gain New Drugs, Piper Analysts Say
By Makiko Kitamura - Mar 4, 2013
GlaxoSmithKline Plc (GSK), the U.K.’s largest drugmaker, may consider acquiring Theravance Inc. (THRX) to fully control respiratory drugs the companies developed together, analysts said.
The Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee will review the two companies’ Breo drug on March 7. Glaxo currently owns 27 percent of Theravance and may pay $51 a share for the remainder, Piper Jaffray analysts said in a note to investors. That’s more than double the closing price on March 1 and would value the remaining stake at about $3.6 billion
burnt shorts on Mon
Skip to content
WebMD: Better information. Better health.
Enter Search Keywords. Use the arrow keys to navigate suggestions.
Treating High Triglycerides
About VASCEPA®
(vas-EE-puh)
The First FDA Approved EPA-only Omega-3
High Triglycerides
Introducing Vascepa (icosapent ethyl)
The First FDA Approved
EPA-only Omega-3
Learn More
High Triglycerides
thanxs
$$
smart
thanxs